Expanded analyses of NAPOLI-1: phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Chen, L Von Hoff, D Li, C Wang-Gillam, A Bodoky, G Dean, A Shan, Y Jameson, G Macarulla, T Lee, K
Chen, L
Von Hoff, D
Li, C
Wang-Gillam, A
Bodoky, G
Dean, A
Shan, Y
Jameson, G
Macarulla, T
Lee, K
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy. 2016, 39:170-170 Oncol Res Treat